Alex is an intellectual property disputes lawyer with twelve years’ experience and a track record of obtaining successful outcomes for clients. He specialises in advising pharmaceutical companies on patent litigation and related matters and has a technical background in genetics.
Alex has represented some of the largest pharmaceutical companies in the world in patent disputes relating to blockbuster antiviral, autoimmunity and chemotherapy medicines. He has also advised on patent matters relating to the generation of monoclonal antibodies. He is experienced in giving freedom-to-operate advice, preparing validity and infringement opinions, advising on patenting and litigation strategy, coordinating litigation and patent office actions around the world, and managing the life cycles of medicines.
Outside of life sciences, Alex has acted in patent litigation in the telecoms and engineering fields against opponents such as Apple, Nokia and Transocean. He has also represented clients in copyright, designs and unfair competition litigation.
Alex’s career to date has been split between the UK and Australia, and he is qualified as a solicitor of England and Wales. He has previously worked for the top-tier IP law practices Bristows and Powell Gilbert in London and Allens in Melbourne. Alex has also served as IP Counsel at United Technologies. There, he supervised the drafting and prosecution of patent applications, giving him a broader perspective on patent matters. Alex joined Pearce IP from Jones Day.
Before pursuing a career in law, Alex spent two years performing laboratory research on bacterial and plant genetics.
World Intellectual Property Review WIPR Leader 2021
World Intellectual Property Review WIPR Leader 2020
At Pearce IP our lawyers and attorneys have “raised the bar” for patent services. We work with life sciences clients to create and implement IP strategies with impact. From conception to post commercialisation our patent professionals provide work that is on point and on time. We help change the world, one patent at a time.